- Home
- VYGR vs NEWP Comparison
VYGR vs NEWP Comparison
Compare VYGR & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- NEWP
- Stock Information
- Founded
- VYGR 2013
- NEWP 1972
- Country
- VYGR United States
- NEWP Canada
- Employees
- VYGR N/A
- NEWP N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- NEWP
- Sector
- VYGR Health Care
- NEWP
- Exchange
- VYGR Nasdaq
- NEWP Nasdaq
- Market Cap
- VYGR 222.9M
- NEWP 223.1M
- IPO Year
- VYGR 2015
- NEWP N/A
- Fundamental
- Price
- VYGR $3.41
- NEWP $1.10
- Analyst Decision
- VYGR Strong Buy
- NEWP Strong Buy
- Analyst Count
- VYGR 9
- NEWP 1
- Target Price
- VYGR $14.86
- NEWP $5.00
- AVG Volume (30 Days)
- VYGR 360.5K
- NEWP 282.7K
- Earning Date
- VYGR 03-11-2025
- NEWP 05-06-2025
- Dividend Yield
- VYGR N/A
- NEWP N/A
- EPS Growth
- VYGR N/A
- NEWP N/A
- EPS
- VYGR N/A
- NEWP N/A
- Revenue
- VYGR $80,001,000.00
- NEWP N/A
- Revenue This Year
- VYGR N/A
- NEWP N/A
- Revenue Next Year
- VYGR $23.46
- NEWP N/A
- P/E Ratio
- VYGR N/A
- NEWP N/A
- Revenue Growth
- VYGR N/A
- NEWP N/A
- 52 Week Low
- VYGR $3.56
- NEWP $0.98
- 52 Week High
- VYGR $10.66
- NEWP $2.53
- Technical
- Relative Strength Index (RSI)
- VYGR 28.74
- NEWP 41.40
- Support Level
- VYGR $3.58
- NEWP $1.22
- Resistance Level
- VYGR $3.96
- NEWP $1.31
- Average True Range (ATR)
- VYGR 0.25
- NEWP 0.08
- MACD
- VYGR -0.01
- NEWP -0.01
- Stochastic Oscillator
- VYGR 2.60
- NEWP 14.21
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.